253 related articles for article (PubMed ID: 29017084)
1. Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir - Case series and 10 year experience of management in an adult transplant cohort.
Ramsay ID; Attwood C; Irish D; Griffiths PD; Kyriakou C; Lowe DM
J Clin Virol; 2017 Nov; 96():73-79. PubMed ID: 29017084
[TBL] [Abstract][Full Text] [Related]
2. Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.
Grimley MS; Chemaly RF; Englund JA; Kurtzberg J; Chittick G; Brundage TM; Bae A; Morrison ME; Prasad VK
Biol Blood Marrow Transplant; 2017 Mar; 23(3):512-521. PubMed ID: 28063938
[TBL] [Abstract][Full Text] [Related]
3. Brincidofovir as Salvage Therapy for Adenovirus Disease in Intestinal Transplant Recipients.
Sulejmani N; Nagai S; Safwan M; Rizzari MD; Raoufi M; Abouljoud MS; Ramesh M
Pharmacotherapy; 2018 Apr; 38(4):470-475. PubMed ID: 29457839
[TBL] [Abstract][Full Text] [Related]
4. Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.
Tollefson AE; Spencer JF; Ying B; Buller RM; Wold WS; Toth K
Antiviral Res; 2014 Dec; 112():38-46. PubMed ID: 25453340
[TBL] [Abstract][Full Text] [Related]
5. New drug on the horizon for treating adenovirus.
Wold WS; Toth K
Expert Opin Pharmacother; 2015; 16(14):2095-9. PubMed ID: 26330121
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus infection in pediatric transplant recipients: are effective antiviral agents coming our way?
Lopez SMC; Michaels MG; Green M
Curr Opin Organ Transplant; 2018 Aug; 23(4):395-399. PubMed ID: 29846196
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus.
Ison MG; Hayden RT
Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726766
[TBL] [Abstract][Full Text] [Related]
8. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
[TBL] [Abstract][Full Text] [Related]
9. The use of brincidofovir for the treatment of mixed dsDNA viral infection.
Camargo JF; Morris MI; Abbo LM; Simkins J; Saneeymehri S; Alencar MC; Lekakis LJ; Komanduri KV
J Clin Virol; 2016 Oct; 83():1-4. PubMed ID: 27513204
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients.
Lee YJ; Neofytos D; Kim SJ; Cheteyan L; Huang YT; Papadopoulos EB; Jakubowski AA; Papanicolaou GA
Transpl Infect Dis; 2018 Dec; 20(6):e12977. PubMed ID: 30120866
[TBL] [Abstract][Full Text] [Related]
11. Brincidofovir as a Salvage Therapy in Controlling Adenoviremia in Pediatric Recipients of Hematopoietic Stem Cell Transplant.
Meena JP; Phillips RS; Kinsey S
J Pediatr Hematol Oncol; 2019 Oct; 41(7):e467-e472. PubMed ID: 30969265
[TBL] [Abstract][Full Text] [Related]
12. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.
Neofytos D; Ojha A; Mookerjee B; Wagner J; Filicko J; Ferber A; Dessain S; Grosso D; Brunner J; Flomenberg N; Flomenberg P
Biol Blood Marrow Transplant; 2007 Jan; 13(1):74-81. PubMed ID: 17222755
[TBL] [Abstract][Full Text] [Related]
13. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
El-Haddad D; El Chaer F; Vanichanan J; Shah DP; Ariza-Heredia EJ; Mulanovich VE; Gulbis AM; Shpall EJ; Chemaly RF
Antiviral Res; 2016 Oct; 134():58-62. PubMed ID: 27582067
[TBL] [Abstract][Full Text] [Related]
14. Successful outcome of a disseminated adenovirus infection 6 years after allogeneic bone marrow transplantation.
Willems L; Lagrange-Xélot M; Gallien S; Robin M; Scieux C; Socié G; Molina JM
Bone Marrow Transplant; 2008 Feb; 41(4):411-2. PubMed ID: 18026146
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.
Florescu DF; Pergam SA; Neely MN; Qiu F; Johnston C; Way S; Sande J; Lewinsohn DA; Guzman-Cottrill JA; Graham ML; Papanicolaou G; Kurtzberg J; Rigdon J; Painter W; Mommeja-Marin H; Lanier R; Anderson M; van der Horst C
Biol Blood Marrow Transplant; 2012 May; 18(5):731-8. PubMed ID: 21963623
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds.
Toth K; Tollefson AE; Spencer JF; Ying B; Wold WSM
Antiviral Res; 2017 Oct; 146():121-129. PubMed ID: 28827083
[TBL] [Abstract][Full Text] [Related]
17. Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant.
Hiwarkar P; Amrolia P; Sivaprakasam P; Lum SH; Doss H; O'Rafferty C; Petterson T; Patrick K; Silva J; Slatter M; Lawson S; Rao K; Steward C; Gassas A; Veys P; Wynn R;
Blood; 2017 Apr; 129(14):2033-2037. PubMed ID: 28153824
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of brincidofovir for Adenovirus infection in children receiving allogeneic stem cell transplantation: an AIEOP retrospective analyses.
Perruccio K; Menconi M; Galaverna F; Pagliara D; Carraro F; Fagioli F; Calore E; Biffi A; Baretta V; Massei MS; Capolsini I; Faraci M; Verna M; Soncini E; Caniglia M; Locatelli F; Cesaro S;
Bone Marrow Transplant; 2021 Dec; 56(12):3104-3107. PubMed ID: 34608274
[No Abstract] [Full Text] [Related]
19. Successful Brincidofovir Treatment of Metagenomics-detected Adenovirus Infection in a Severely Ill Signal Transducer and Activator of Transcription-1-deficient Patient.
Averbuch D; Safadi R; Dar D; Wolf D; Cherniak M; Sorek R; Amit S
Pediatr Infect Dis J; 2019 Mar; 38(3):297-299. PubMed ID: 29742642
[TBL] [Abstract][Full Text] [Related]
20. Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients: A case series.
Londeree J; Winterberg PD; Garro R; George RP; Shin S; Liverman R; Serluco A; Romero R; Yildirim I
Pediatr Transplant; 2020 Nov; 24(7):e13769. PubMed ID: 32558134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
